Norway’s Svalbard Global Seed Vault or the Doomsday vault, as it is more commonly known, is home to countless species of plants and crops. The facility is meant to house and protect these seeds so that in the event of a nuclear war or a natural calamity that leads to the apocalypse, there is a chance to regrow the food that was lost. Recently, 50,000 new seed samples that were collected from all over the world were placed in the vault for safekeeping.
There are other seed deposits all over, but the one in Norway is the most significant and is the best protected. This is meant to ensure that if all the other seed deposits were lost, the underground facility that is buried under permafrost for better preservation will get the job done, Phys.org reports.
Aside from the fact that there are now more seeds that will be preserved, many of the seeds sent are also a result of reconstitution. These are seeds that will be perfect for planting in dry, hot regions, which may make them necessary for when the world gets a little too hot for more delicate samples.
As the head of the International Center for Agricultural Research, Aly Abousabaa said on Thursday, what they were able to achieve with the reconstituted seeds that they then stored puts them one step closer to being able to "find solutions to pressing regional and global challenges." The researchers who reconstituted the seeds even had to borrow them from other seed banks.
The vault itself is the brainchild of Cary Fowler, which sees the vault as something of a safety deposit box, Futurism reports. While it can certainly function as a means of populating the world with plants and other botanical organisms in the case of a major catastrophe, plants species die off all the time. The vault can help out with bringing them back as well.


CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Neuralink Expands Brain Implant Trials with 12 Global Patients
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 



